Investing Profile

Laura Stoppel

InvestorVC
Principal at RA Capital
racap.comSomerville, Massachusetts
Photo of Laura Stoppel, Principal at RA Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
RA Capital Principal
$100K - $5.0M
$100K
12
CompanyStageDateRound SizeTotal Raised
Contraline
Series BJun 2026$93M
$120M
Co-investors: Jason Calacanis (Sequoia Capital), Gurdane Bhutani (MBX Capital), Ramtin Naimi (Abstract Ventures), Cyan Banister (Long Journey Ventures), Jaffray Woodriff, Bill Smith
CellCentric
Series DMay 2026$220M
Series CMay 2025$120M
Series UnknownJul 2024$35M
$380M
Co-investors: Jasper Bos (Forbion)
Gameto
Series CAug 2025$44M
Series BMay 2024$33M
$120M
Co-investors: Dan Rose (Coatue), Dylan Morris (Insight Partners), Peter Kolchinsky (RA Capital), Steve Jurvetson (Baruch Future Ventures), Anne Wojcicki (23andMe), Maryanna Saenko (Baruch Future Ventures), Robert Nelsen (ARCH Venture Partners), Viktoriya Tigipko (TA Ventures), Jack Abraham (Atomico), Dusan Perovic (Two Sigma Ventures), Kristina Simmons (Overwater Ventures)
Nimbus Therapeutics
Series UnknownSep 2022$130M
Series UnknownJul 2021$110M
Series UnknownOct 2020$60M
$640M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Bruce Booth (Atlas Venture), Vicki Sato (ARCH Venture Partners), Rajeev Dadoo (SR One), Peter Kolchinsky (RA Capital), Nikola Trbovic (Pfizer Venture Investments), Bill Gates
Indapta Therapeutics
Series AFeb 2022$50M
$50M
Co-investors: Lori Hu (Vertex Ventures)
Artiva Biotherapeutics
Series BFeb 2021$120M
Series AJun 2020$78M
$200M
Co-investors: Brian Daniels (5am Ventures), Yvonne Yamanaka (venBio), Bong Koh (Venrock)